COMP <GO>
BAX vs UNH // 10Y YIELD & FRED MACRO BETA
Baxter International Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BAX 2
— UNH 11
▲ 10Y YIELD & FRED MACRO BETA LEADER: BAX
LAST: $23.50 (-7.70%) • MKT CAP: $12.15B
macro-sensitivity
0.95
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BAX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BAX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.10% | 88.57% | -58.47 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.40% | 11.47% | -13.87 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.79% | 6.48% | -3.69 | UNH | /fcf-yield <GO> |
| Operating Margin | -2.70% | 4.82% | -7.52 | UNH | /operating-margins <GO> |
| Net Profit Margin | -8.50% | 3.14% | -11.64 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 5.70% | 6.46% | -0.76 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.86% | 2.28% | +0.58 | BAX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 3.12 | -0.90 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.3 | 59.2 | -16.90 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.95 | 0.33 | +0.62 | BAX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 17.1x | +0.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.15B | $368.83B | -$356.68B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BAX REV | UNH REV | BAX GROSS % | UNH GROSS % | BAX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.24B | $447.57B | 30.1% | 88.7% | $339.0M | $16.07B |
| FY 2024 | $10.64B | $400.28B | 37.5% | 88.3% | $540.4M | $20.70B |
| FY 2023 | $10.36B | $371.62B | — | 89.6% | $1.26B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BAX // BETA 0.95
UNH // BETA 0.33